NovoCure Ltd (NVCR) insider trading

By person

33 insiders · 970 transactions

12.8×

Frank Leonard holds 12.8 times base salary in stock. $7.30M of shares against $570.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Frank Leonard last reported holding, valued at $13.24, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Asaf Danziger

Director

$509.54K (3)

$201.82M (101) scheduled

−$201.31M

604,831

$8.01M

−48.8%

William F Doyle

Executive Chairman

—

$73.23M (51)

−$73.23M

1,320,075

$17.48M

−94.1%

Wilhelmus Cm Groenhuysen

Chief Operating Officer

—

$64.69M (183) scheduled

−$64.69M

530,347

$7.02M

+27.2%

Michael J. Ambrogi

Chief Operating Officer

—

$44.13M (73) scheduled

−$44.13M

441,734

$5.85M

−26.1%

Todd Christopher Longsworth

General Counsel

—

$31.10M (57) scheduled

−$31.10M

130,176

$1.72M

+86.7%

Pritesh Shah

Chief Growth Officer

$357.05K (1)

$26.50M (77)

−$26.14M

202,397

$2.68M

+113.1%

Eilon D. Kirson

Chief Science Officer

—

$24.29M (19) scheduled

−$24.29M

152,408

$2.02M

−14.4%

Gabriel Leung

Director

—

$24.16M (52) scheduled

−$24.16M

101,109

$1.34M

—

Pomona Capital VII, L.P. entity

10% owner

—

$18.61M (4)

−$18.61M

2,741,925

$36.30M

−28.1%

Yoram Palti

Chief Technology Officer

—

$15.75M (73)

−$15.75M

1,041,054

$13.78M

−42.8%

Frank X Leonard

Chief Executive Officer

—

$13.29M (64)

−$13.29M

551,470

$7.30M

+232.8%

W Anthony Vernon

Director

—

$9.19M (4)

−$9.19M

209,267

$2.77M

−16.0%

Charles G Phillips III

Director

—

$9.02M (11) scheduled

−$9.02M

3,359

$44.47K

—

Ely Benaim

Chief Medical Officer

—

$5.72M (26) scheduled

−$5.72M

64,947

$859.84K

+45.7%

Uri Weinberg

Chf Medical and Innovation Ofr

—

$5.60M (16) scheduled

−$5.60M

303,496

$4.02M

+428.8%

Ashley Cordova

Former Chief Executive Officer

$996.86K (1)

$5.45M (26) scheduled

−$4.45M

458,463

$6.07M

+754.1%

Gert L. Perlhagen

Director

$866.25K (1)

—

+$866.25K

6,125,000

$81.09M

—

Mukund Paravasthu

Chief Operating Officer

—

$810.07K (12)

−$810.07K

72,832

$964.23K

+1,888%

William Patrick Burke

Chief Human Resources Officer

—

$651.32K (10)

−$651.32K

66,447

$879.70K

+153.5%

Jeryl L Hilleman

Director

—

$508.02K (4)

−$508.02K

25,471

$337.21K

—

Christoph Brackmann

Chief Financial Officer

$231.80K (3)

$85.31K (1)

+$146.49K

182,842

$2.42M

+176.3%

Timothy J Scannell

Director

—

$86.77K (3)

−$86.77K

25,898

$342.87K

+34,431%

Michal Nath Puri

Chief Human Resources Officer

—

$83.63K (6)

−$83.63K

202,567

$2.68M

+20,256,600%

David Hung

Director

—

$63.72K (2)

−$63.72K

32,075

$424.64K

—

Allyson J Ocean

Director

—

$63.71K (2)

−$63.71K

22,934

$303.63K

—

Kristin Stafford

Director

—

$63.70K (2)

−$63.70K

22,934

$303.63K

—

Nicolas Leupin

Former Chief Medical Officer

—

$48.54K (4)

−$48.54K

102,979

$1.36M

—

Martin J. Madden

Director

—

$22.38K (2)

−$22.38K

31,086

$411.55K

+7,337%

Hansjoerg Wyss

10% owner

—

9,780,397

$129.48M

−9.3%

Arye Barak Ben

General Counsel

—

243,752

$3.23M

+1,337%

Moshe Giladi

Chief Science Officer

—

69,771

$923.71K

+274.2%

William T. Burkoth

Director

—

6,145

$81.35K

—

Peter M. Melnyk

Chief Commercial Officer

—

2,403

$31.81K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

NovoCure Ltd

What the insiders did Net selling

By person